Serum miR-503 is a Candidate Biomarker for Differentiating Metabolic Healthy Obesity from Metabolic Unhealthy Obesity.

Hai-Qing YueYing-Hui ZhouYue GuoChen-Yi TangFang WangHou-De Zhou

Published in: Diabetes, metabolic syndrome and obesity : targets and therapy (2020)

miR-503 can be considered as a suitable biomarker to distinguish between the MUO and MHO, which may be a related factor for the incidence of metabolic disorders in overweight/obese subjects.

Keyphrases

weight loss
metabolic syndrome
cell proliferation
weight gain
long non coding rna
type diabetes
insulin resistance
bariatric surgery
long noncoding rna
adipose tissue
high fat diet induced
physical activity
body mass index
obese patients
computed tomography